Suchergebnisse - "Ravetch, Jeffrey V"

PubPharm (107)

1

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

enthalten in: Cancer immunology research | 2024

von Knorr, D. | Blanchard, L. | Leidner, R. | +14

UpdateOf: bioRxiv. 2023 Jan 20;:. - PMID 36711504

2

The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions

enthalten in: Cancer cell | 2023

von Osorio, J. | Smith, P. | Knorr, D. | +1

UpdateOf: bioRxiv. 2023 Jun 29;:. - PMID 37455857

3

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Wong, J. | Smith, P. | Angulo-Lozano, J. | +6

UpdateOf: bioRxiv. 2023 Feb 01;:. - PMID 36778311

4

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

enthalten in: Nature communications | 2023

von Gupta, A. | Kao, K. | Yamin, R. | +6

UpdateOf: bioRxiv. 2023 Jan 24;:. - PMID 36747840

5

Synthetic nanobodies as tools to distinguish IgG Fc glycoforms

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Kao, K. | Gupta, A. | Zong, G. | +7

6

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine

enthalten in: Nature immunology | 2022

von Herati, R. | Knorr, D. | Vella, L. | +25

CommentIn: Nat Immunol. 2022 Aug;23(8):1135-1137. - PMID 35902636

7

Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

enthalten in: Nature | 2021

von Yamin, R. | Jones, A. | Hoffmann, H. | +8

UpdateOf: Res Sq. 2021 May 27;:. - PMID 34075373

8

Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Ibarlucea-Benitez, I. | Weitzenfeld, P. | Smith, P. | +1

9

Antibody fucosylation predicts disease severity in secondary dengue infection

enthalten in: Science (New York, N.Y.) | 2021

von Bournazos, S. | Vo, H. | Duong, V. | +6

CommentIn: Science. 2021 Jun 4;372(6546):1041-1042. - PMID 34083476

10

Site-Selective Chemoenzymatic Modification on the Core Fucose of an Antibody Enhances Its Fcγ Receptor Affinity and ADCC Activity

enthalten in: Journal of the American Chemical Society | 2021

von Li, C. | Chong, G. | Zong, G. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]